Krystal Biotech Ownership | Who Owns Krystal Biotech?
Krystal Biotech Ownership Summary
Krystal Biotech is owned by 100.60% institutional investors, 10.64% insiders. Fmr is the largest institutional shareholder, holding 15.04% of KRYS shares. Fidelity Select Biotechnology is the top mutual fund, with 6.09% of its assets in Krystal Biotech shares.
KRYS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Krystal Biotech | 100.60% | 10.64% | -11.24% |
| Sector | Healthcare Stocks | 129.28% | 12.06% | -41.34% |
| Industry | Biotech Stocks | 181.42% | 11.67% | -93.09% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Fmr | 4.44M | 15.04% | $1.48B |
| Blackrock | 3.95M | 13.95% | $724.98M |
| Blackrock funding, inc. /de | 3.59M | 12.16% | $1.19B |
| Avoro capital advisors | 2.89M | 9.86% | $1.07B |
| Vanguard group | 2.78M | 9.60% | $685.10M |
| State street | 1.42M | 4.81% | $472.26M |
| Vanguard portfolio management | 1.29M | 4.36% | $427.96M |
| Vanguard capital management | 1.20M | 4.05% | $397.97M |
| Soleus capital management | 939.25K | 3.21% | $349.09M |
| Geode capital management | 811.74K | 2.75% | $270.00M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Redmile group | 632.00K | 15.77% | $234.90M |
| Soleus capital management | 939.25K | 12.03% | $349.09M |
| Act capital management | 45.00K | 10.93% | $16.73M |
| Avoro capital advisors | 2.89M | 9.64% | $1.07B |
| Act capital partners | 42.00K | 9.07% | $13.97M |
| S squared | 77.55K | 8.94% | $28.82M |
| Vestor capital | 700.91K | 4.91% | $78.19M |
| Evolutionary tree capital management | 7.13K | 4.40% | $2.37M |
| Frazier life sciences management | 481.31K | 3.90% | $178.89M |
| Biondo investment advisors | 71.23K | 2.82% | $23.69M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock | 3.95M | 0.02% | 2.14M |
| Norges bank | 259.03K | 0.01% | 259.03K |
| Price t rowe associates inc /md/ | 687.40K | 0.03% | 202.33K |
| Geode capital management | 811.74K | 0.01% | 112.74K |
| Franklin resources | 370.95K | 0.02% | 109.03K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blackrock funding, inc. /de | 3.59M | 0.02% | -590.80K |
| Bellevue group | 77.53K | 0.61% | -404.25K |
| Vanguard portfolio management | 1.29M | 0.02% | -288.05K |
| First trust advisors lp | 49.27K | 0.01% | -275.63K |
| Sixth street partners management company | - | - | -254.83K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Norges bank | 259.03K | 0.01% | 259.03K | $96.27M |
| Capital impact advisors | 80.08K | 2.30% | 80.08K | $26.63M |
| Eagle asset management | 76.26K | 0.07% | 76.26K | $13.90M |
| Lord, abbett | 71.25K | 0.07% | 71.25K | $23.69M |
| Act capital partners | 42.00K | 9.07% | 42.00K | $13.97M |
Sold Out
| Holder | Change |
|---|---|
| Tfc financial management | -1.00 |
| Tradewinds capital management | -1.00 |
| Ameritas advisory services | -1.00 |
| Davis capital management | -1.00 |
| Abound wealth management | -1.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | 465 | 4.97% | 29,707,231 | -2.78% | 100 | 0.92% | 263 | -3.66% | 122 | 7.02% |
| Jun 30, 2026 | 435 | 14.47% | 30,510,929 | 7.56% | 104 | 1.08% | 268 | 24.65% | 110 | 4.76% |
| Mar 31, 2026 | 234 | -31.78% | 12,018,941 | -57.72% | 41 | 0.43% | 135 | -30.77% | 60 | -43.40% |
| Dec 31, 2025 | 232 | -22.15% | 16,100,358 | -42.52% | 55 | 0.59% | 128 | -16.88% | 74 | -12.94% |
| Sep 30, 2025 | 289 | 4.33% | 27,787,336 | 3.78% | 96 | 1.12% | 149 | 7.19% | 83 | -10.75% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 1.80M | 6.09% | - |
| iShares Core S&P Small-Cap ETF | 1.58M | 5.36% | 222.00 |
| Fidelity Growth Compy Commingled Pl S | 1.07M | 3.62% | 20.90K |
| iShares Core S&P Mid-Cap ETF | 957.57K | 3.23% | 504.00 |
| Fidelity Growth Compy Commingled Pl O | 915.43K | 3.19% | - |
| Vanguard Total Stock Mkt Idx Inv | 889.73K | 3.02% | 51.28K |
| Vanguard Morn Total Stk Mkt Idx Investor | 889.73K | 3.02% | 51.28K |
| Vanguard MStar Total Stk Mkt Idx Invest | 848.20K | 2.87% | -43.23K |
| Vanguard US Total Market Shares ETF | 824.72K | 2.86% | 704.00 |
| Fidelity Growth Company Fund | 816.13K | 2.76% | 6.63K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Sep 04, 2026 | Krishnan Suma | President, R&D | Sell | $1.16M |
| Sep 04, 2026 | Krishnan Suma | President, R&D | Sell | $1.42M |
| Sep 04, 2026 | Krishnan Suma | President, R&D | Sell | $184.36K |
| Sep 04, 2026 | Krishnan Suma | President, R&D | Sell | $713.28K |
| Sep 04, 2026 | Krishnan Suma | President, R&D | Sell | $1.14M |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q4 | - | - |
| 2026 Q3 | - | 34 |
| 2026 Q2 | - | 24 |
| 2026 Q1 | - | 52 |
| 2025 Q4 | - | 32 |
KRYS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools